therapeutic trials have shown aztreonam to be effective in gram-negative infections including complicated infections of the urinary tract , in lower respiratory tract infections and in gynaecological and obstetric , intra-abdominal , joint and bone , skin and soft tissue infections , uncomplicated gonorrhoea and septicaemia .
C0004521
aztreonam
C0036690
septicaemia